Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIG1 | P18858 | 1/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.47 |
| ▸ | TPMT | P51580 | 1/20 | 0.46 |
| ▸ | CDC25B | P30305 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ITGA1 | P56199 | 1/20 | 0.42 |
| ▸ | CDC25A | P30304 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3838111 | 0.91 | AKR1C3 (0.50) | LIG1AKR1C3CDC25BATMNR4A1 | |
| SCHEMBL3845299 | 0.89 | AKR1C3 (0.54) | LIG1AKR1C3CDC25BATMCA1 | |
| SCHEMBL3843129 | 0.87 | AKR1C3 (0.56) | LIG1AKR1C3TPMTCDC25BATM | |
| SCHEMBL3846158 | 0.87 | AKR1C3 (0.56) | LIG1AKR1C3TPMTCDC25BATM | |
| SCHEMBL154090 | 0.87 | AKR1C3 (0.61) | AKR1C3CDC25BATMNR4A1MEN1 | |
| SCHEMBL31641074 | 0.84 | NR4A1 (0.65) | NR4A1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL3843545 | 0.82 | SRD5A2 (0.55) | KMT2AMAPTALDH1A1 | |
| SCHEMBL1298701 | 0.82 | MEN1 (0.54) | AKR1C3CDC25BCA1CA2MEN1 | |
| SCHEMBL7650897 | 0.82 | AKR1C3 (0.73) | AKR1C3TPMTCDC25BATMCA1 | |
| SCHEMBL29385980 | 0.80 | KMT2A (0.62) | LIG1AKR1C3TPMTCDC25BATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019198607-A1 | ALKENYL-GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, AND CURED OBJECT OBTAINED THEREFROM | 日本化薬株式会社 | 2019-10-17 | — | — | WO | disclosed |
| EP-1329444-B1 | Halogenated aromatic compound, (co)polymer thereof, and proton-conductive membrane comprising same | JSR CORP (JP) | 2010-05-05 | — | — | EP | disclosed |
| EP-1245638-B1 | Composition for insulating film formation | JSR CORP (JP) | 2009-01-14 | — | — | EP | disclosed |
| EP-1138712-B1 | Polyarylene copolymers and proton-conductive membrane | JSR CORP (JP) | 2006-01-18 | — | — | EP | disclosed |
| US-6933068-B2 | Polymer electrolyte membrane and solid polymer electrolyte fuel cell using same | HONDA GIKEN KOGYO KABUSHIKI KAISHA (JP) | 2005-08-23 | — | — | US | disclosed |
| US-6852370-B2 | Composition for film formation and material for insulating film formation | JSR CORPORATION (JP) | 2005-02-08 | — | — | US | disclosed |
| US-6833426-B2 | A proton-conductive membrane containing the sulfonic acid group-containing polyarylene (co)polymer | JSR CORPORATION (JP) | 2004-12-21 | — | — | US | disclosed |
| US-6812290-B2 | FOR USE AS ELECTROLYTES | JSR CORPORATION (JP) | 2004-11-02 | — | — | US | disclosed |
| US-20030195301-A1 | Polyarylene copolymers and proton-conductive membrane | JSR CORPORATION (JP) | 2003-10-16 | — | — | US | disclosed |
| US-20030173547-A1 | Halogenated aromatic compound, (co)polymer thereof, and proton-conductive membrane comprising same | JSR CORPORATION (JP) | 2003-09-18 | — | — | US | disclosed |
| EP-1329444-A1 | Halogenated aromatic compound, (co)polymer thereof, and proton-conductive membrane comprising same | JSR Corporation (JP) | 2003-07-23 | — | — | EP | disclosed |
| US-6555626-B2 | Controlled amount of sulfonic acid groups; copolymer of an aromatic compound having a main chain containing electron withdrawing groups and aromatic compounds with no electron withdrawing groups; durability, strength, conductivity | JSR CORPORATION (JP) | 2003-04-29 | — | — | US | disclosed |
| US-20020172652-A1 | Composition for film formation and material for insulating film formation | JSR CORPORATION (JP) | 2002-11-21 | — | — | US | disclosed |
| US-20020172850-A1 | Polymer electrolyte membrane and solid polymer electrolyte fuel cell using same | HONDA GIKEN KOGYO KABUSHIKI KAISHA, JSR CORPORATION | 2002-11-21 | — | — | US | disclosed |
| EP-1245638-A1 | Composition for insulating film formation | JSR Corporation (JP) | 2002-10-02 | — | — | EP | disclosed |
| US-20010037000-A1 | Polyarylene copolymers and proton-conductive membrane | JSR CORPORATION (JP) | 2001-11-01 | — | — | US | disclosed |
| EP-1138712-A2 | Polyarylene copolymers and proton-conductive membrane | JSR Corporation (JP) | 2001-10-04 | — | — | EP | disclosed |
| US-5298574-A | Copolymerizing in presence of n-methyl-2-pyrrolidone, sodium carbonate and sodium hydrogen sulfide | PHILLIPS PETROLEUM COMPANY (US) | 1994-03-29 | — | — | US | disclosed |
| US-5298573-A | Poly(arylene sulfide sulfone)/poly(arylene sulfide ketone) block copolymers and preparation thereof | PHILLIPS PETROLEUM COMPANY (US) | 1994-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020172652-A1 | Composition for film formation and material for insulating film formation | VCL, BMI1, PUF60 | LIG1 1738/4885AKR1C3 3015/4885TPMT 2629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.